New Analyses Suggest Favorable Results for STELARA® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, Pa., Oct. 25, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Corporations of Johnson & Johnson at the moment introduced ...
![The 10 Best Weight Loss Gummies [Reviewed & Tested]](https://nutritioncenter.extremefatloss.org/wp-content/uploads/2022/05/29029179_web1_M1-VIB-20220505-Best-Weight-Loss-Gummies-Teaser-120x86.jpeg)
